KCM
NPSP

Kingdon Capital Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Kingdon Capital Management’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-50,000
Closed -$1.52M – 232
2013
Q4 		$1.52M Buy
+50,000
New +$1.38M 0.07% 162
2013
Q3 		– Sell
-89,000
Closed -$1.34M – 255
2013
Q2 		$1.34M Buy
+89,000
New +$1.23M 0.08% 177

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Kingdon Capital Management's NPSP Position: Q1 2014 in Review

Kingdon Capital Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2014, closing a stake of 50,000 shares — an estimated $1.52M sold.

Kingdon Capital Management first reported a position in NPSP in Q2 2013 and held it in 2 quarters. The position peaked at $1.52M in Q4 2013. 210 funds tracked by Wall St. Rank hold NPSP as of Q1 2014.

  • Kingdon Capital Management reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Kingdon Capital Management sold 50,000 NPS PHARMACEUTICALS INC shares in Q1 2014, an estimated $1.52M.
  • Kingdon Capital Management first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Kingdon Capital Management's NPS PHARMACEUTICALS INC position peaked at $1.52M in Q4 2013.
  • 210 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2014.

Based on Kingdon Capital Management's 13F filing for Q1 2014, filed 15 May 2014.